William Blair Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform, ‘Sets Up Second Half 2024 Approval and Launch’

Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/William+Blair+Upgrades+ARS+Pharmaceuticals+Inc+%28SPRY%29+to+Outperform%2C+%27Sets+Up+Second+Half+2024+Approval+and+Launch%27/22801410.html for the full story.